Structural & Congenital Heart Disease

The Society of Cardiovascular Computed Tomography (SCCT) released updated guidelines for using CT imaging in patients undergoing transcatheter aortic valve replacement (TAVR).

The first United States patient has been treated with the J-Valve TF system designed to address one of the holes in the rapidly evolving TAVR field: the lack of devices specifically targeting pure aortic regurgitation.

Ramping up the battle against cardiovascular disease in women represents a golden opportunity to move the needle on mortality.

Will operators be able to replicate COAPT’s restraint & its outcomes?

Three more executives resigned from Johns Hopkins All Children’s Hospital in St. Petersburg, Florida, in the continued fallout from an investigation by the Tampa Bay Times that revealed mortality rates tripled over just a few years in the pediatric heart surgery unit.

The Sapien 3 Ultra heart valve has received FDA approval for transcatheter aortic valve replacement (TAVR) in patients with severe, symptomatic aortic stenosis who are considered to be at intermediate or high risk of open-heart surgery, device manufacturer Edwards Lifesciences announced on Dec. 28.

Publicly posted hospital ratings could be confusing heart patients more than helping them, Reuters reported of a Journal of the American College of Surgeons study that found significant disparities between major rating systems in the U.S.

The severity of left ventricular dysfunction at baseline didn’t appear to impact survival after transcatheter aortic valve replacement (TAVR) in a substudy of patients with low-flow, low-gradient (LFLG) aortic stenosis, suggesting TAVR is an acceptable treatment in this high-risk population.

The psychosocial status of adults living with congenital heart disease (CHD) has improved over the past couple of decades, researchers report of a cross-sectional study that analyzed CHD patients’ quality of life between 1995 and 2015.

Three administrators at Johns Hopkins All Children’s Hospital, including the CEO, have resigned following a report from the Tampa Bay Times that found mortality rates tripled in the pediatric heart surgery unit from 2015 to 2017—even as the center began to turn away more challenging cases.

Hospitals with favorable outcomes for surgical aortic valve replacement (SAVR) procedures subsequently see better transcatheter aortic valve replacement (TAVR) outcomes when they launch TAVR programs, researchers reported in JAMA Cardiology Dec. 5, suggesting the quality of an institution’s surgical team could be an indicator of how they’ll fare after they initiate TAVR.

High-risk transcatheter aortic valve replacement (TAVR) patients see the same rates of functional recovery and survival as surgical aortic valve replacement (SAVR) patients half a decade after their procedures, according to data published in the Journal of the American College of Cardiology.